Results 31 to 40 of about 67,505 (283)

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus

open access: yesPathogens, 2020
A clinical trial performed in the Democratic Republic of Congo (DRC), among persons with epilepsy (PWE) infected with Onchocerca volvulus treated with anti-seizure medication suggested that ivermectin reduces the seizure frequency. We assessed the effect
Alfred Dusabimana   +9 more
doaj   +1 more source

Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial

open access: yesAsian Pacific Journal of Tropical Medicine, 2021
Objective: To evaluate different doses of ivermectin in adult patients with mild COVID-19 and to evaluate the effect of ivermectin on mortality and clinical consequences. Methods: A randomized, double-blind, placebo-controlled, multicenter clinical trial
Morteza Shakhsi Niaee   +14 more
doaj   +1 more source

Transition from endemic behavior to eradication of malaria due to combined drug therapies: an agent-model approach [PDF]

open access: yes, 2019
We introduce an agent-based model describing a susceptible-infectious-susceptible (SIS) system of humans and mosquitoes to predict malaria epidemiological scenarios in realistic biological conditions.
Lind, Pedro G.   +3 more
core   +2 more sources

The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19

open access: yesmedRxiv, 2020
Caly et al.1 reported that ivermectin inhibited severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) in vitro for up to 48 hours using ivermectin at 5 μM.
V. Schmith, Jie Zhou, L. Lohmer
semanticscholar   +1 more source

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

open access: yesBMC Infectious Diseases, 2021
Background and objectives An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day.
N. Okumus   +14 more
semanticscholar   +1 more source

Identification of the metabolites of ivermectin in humans

open access: yesPharmacology Research & Perspectives, 2021
Mass drug administration of ivermectin has been proposed as a possible malaria elimination tool. Ivermectin exhibits a mosquito‐lethal effect well beyond its biological half‐life, suggesting the presence of active slowly eliminated metabolites.
Phornpimon Tipthara   +9 more
doaj   +1 more source

Nematode control in suckler beef cattle over their first two grazing seasons using a targeted selective treatment approach [PDF]

open access: yes, 2015
peer-reviewedBackground With concerns over the development of anthelmintic resistance in cattle nematode populations, we must re-examine our approach to nematode control in cattle.
Barrett, Damien   +6 more
core   +1 more source

Human myiasis in Ecuador. [PDF]

open access: yes, 2020
We review epidemiological and clinical data on human myiasis from Ecuador, based on data from the Ministry of Public Health (MPH) and a review of the available literature for clinical cases.
Calvopina, M   +5 more
core   +1 more source

Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study

open access: yesJournal of Medical Virology, 2021
Researchers around the world are working at record speed to find the best ways to treat and prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of ivermectin for the treatment of hospitalized mild to moderate COVID‐19 ...
S. Abd-Elsalam   +15 more
semanticscholar   +1 more source

Modelling the consequences of targeted selective treatment strategies on performance and emergence of anthelmintic resistance amongst grazing calves [PDF]

open access: yes, 2016
The development of anthelmintic resistance by helminths can be slowed by maintaining refugia on pasture or in untreated hosts. Targeted selective treatments (TST) may achieve this through the treatment only of individuals that would benefit most from ...
Berk, Zoe   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy